Lung Foundation Australia and Cancer Australia are pleased to announce the successful applicant to the 2021 round of the Priority-driven Collaborative Cancer Research Scheme (PdCCRS).
Congratulations to Dr Ashleigh Poh, Olivia Newton-John Cancer Research Institute, La Trobe University who receives funding to support her project, Targeting the myeloid-specific kinase HCK in non-small cell lung cancer to improve response to therapy. The grant is co-funded by Cancer Australia and Lung Foundation Australia.
A full list of successful applicants for the 2021 round can be found via the Cancer Australia website here.
Lung Foundation Australia is proud to provide support for this program through our Hope Research Fund, which was launched in early 2021. The Hope Research Fund is our powerful pledge to raise $50 million by 2030 to fund life-changing advancements in lung disease and lung cancer research.
How you can support life-changing research
45 Australian families lose a loved one to lung disease and lung cancer every day.
With more money invested into discovering scientific breakthroughs we will bring new hope to millions of Australians impacted by lung disease and lung cancer, like Ethan who lives with bronchiectasis.
Give hope. Give to research this Christmas.
